Glatiramer acetate in patients with relapsing-remitting multiple sclerosis; a "real-life" observational study.
Phase of Trial: Phase IV
Latest Information Update: 17 Aug 2015
At a glance
- Drugs Glatiramer acetate (Primary)
- Indications Multiple sclerosis
- Focus Therapeutic Use
- Acronyms SUCESS
- 17 Aug 2015 New trial record
- 23 Jun 2015 Results presented at the 1st Congress of the European Academy of Neurology.